SASAKI Ryu 佐々木龍

… Alternative Names

Sasaki Ryu 佐々木龍

Less

Researcher Number	90834854
Affiliation (Current)	2025: 長崎大学, 病院(医学系), 助教
Affiliation (based on the past Project Information) *help	2020 – 2024: 長崎大学, 病院(医学系), 助教
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Basic Section 53010:Gastroenterology-related
Keywords	Principal Investigator 肝細胞癌 / 免疫微小環境 / EOB-MRI / 有害事象 / lenvatinib / BDNF / マイオカイン / 分子標的薬 / Lenvatinib / 血漿マイオカイン

Research Projects
(2 results)
Research Products
(19 results)

EOB-MRIによる免疫微小環境推定モデルを用いた肝細胞癌薬物療法の治療効果予測Principal Investigator
- Principal Investigator
  
  佐々木龍
- Project Period (FY)
  2024 – 2027
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Nagasaki University
A model for predicting adverse events in molecular targeted drug therapy for hepatocellular carcinomaPrincipal Investigator
- Principal Investigator
  
  Sasaki Ryu
- Project Period (FY)
  2020 – 2023
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Nagasaki University

All 2024 2022 2021 2020

All Journal Article Presentation

[Journal Article] Impact of lenvatinib on renal function compared to sorafenib for unresectable hepatocellular carcinoma2022
- Author(s)
  Sasaki Ryu、Fukushima Masanori、Haraguchi Masafumi、Honda Takuya、Miuma Satoshi、Miyaaki Hisamitsu、Nakao Kazuhiko
- Journal Title
  
  Medicine
  
  Volume: 101 Issue: 19 Pages: e29289-e29289
- DOI
  10.1097/md.0000000000029289
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K16993, KAKENHI-PROJECT-19K17497
[Journal Article] Long-term Outcomes and Prognostic Factors of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma2022
- Author(s)
  NAGATA KAZUYOSHI、SASAKI RYU、IWATSU SHINICHI、FUKUSHIMA MASANORI、HARAGUCHI MASAFUMI、YAMAMICHI SHINOBU、MIUMA SATOSHI、MIYAAKI HISAMITSU、TAURA NAOTA、YAMAZAKI TAKUYA、NAKAO KAZUHIKO
- Journal Title
  
  Anticancer Research
  
  Volume: 42 Issue: 10 Pages: 5001-5007
- DOI
  10.21873/anticanres.16007
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K16993, KAKENHI-PROJECT-19K17497
[Journal Article] Evaluating the Role of Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Predicting Treatment Impact of Lenvatinib and Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma2022
- Author(s)
  Sasaki Ryu、Nagata Kazuyoshi、Fukushima Masanori、Haraguchi Masafumi、Miuma Satoshi、Miyaaki Hisamitsu、Soyama Akihiko、Hidaka Masaaki、Eguchi Susumu、Shigeno Masaya、Yamashima Mio、Yamamichi Shinobu、Ichikawa Tatsuki、Kugiyama Yuki、Yatsuhashi Hiroshi、Nakao Kazuhiko
- Journal Title
  
  Cancers
  
  Volume: 14 Issue: 3 Pages: 827-827
- DOI
  10.3390/cancers14030827
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K16993, KAKENHI-PROJECT-21K07916, KAKENHI-PROJECT-19K17497
[Journal Article] Liver Function in Older Patients With Unresectable Hepatocellular Carcinoma After Administration of Lenvatinib2021
- Author(s)
  SASAKI RYU
- Journal Title
  
  Anticancer Research
  
  Volume: 41 Issue: 4 Pages: 2025-2032
- DOI
  10.21873/anticanres.14970
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K16993
[Presentation] 切除不能進行肝癌薬物療法（Lenvatinib）における血漿マイオカイン測定の意義2024
- Author(s)
  佐々木龍
- Organizer
  第30回日本肝癌分子標的治療研究会
- Data Source
  KAKENHI-PROJECT-20K16993
[Presentation] Evaluating the Role of Hepatobiliary Phase of EOB-MRI in Predicting Treatment Impact of Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma2022
- Author(s)
  Ryu Sasaki, Kazuhiko Nakao
- Organizer
  APASL Oncology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K16993
[Presentation] 切除不能進行肝癌に対する薬物療法の治療効果予測とEOB-MRIの有用性2022
- Author(s)
  佐々木龍、中尾一彦
- Organizer
  JDDW 2022
- Data Source
  KAKENHI-PROJECT-20K16993
[Presentation] 切除不能進行肝癌薬物療法における治療前EOB-MRI評価の有用性2022
- Author(s)
  佐々木龍、中尾一彦
- Organizer
  第58回日本肝癌研究会
- Data Source
  KAKENHI-PROJECT-20K16993
[Presentation] 実臨床におけるAtezolizumab＋Bevacizumab併用療法の後治療2022
- Author(s)
  佐々木龍、中尾一彦
- Organizer
  第120回消化器病学会九州支部例会
- Data Source
  KAKENHI-PROJECT-20K16993
[Presentation] Atezolizumab/Bevacizumab併用療法の治療効果予測におけるEOB-MRIの有用性2022
- Author(s)
  佐々木龍、中尾一彦
- Organizer
  第26回肝がん分子標的治療研究会
- Data Source
  KAKENHI-PROJECT-20K16993
[Presentation] 免疫複合療法時代に再考する切除不能進行肝癌Lenvatinib長期使用例の特徴2022
- Author(s)
  佐々木龍、中尾一彦
- Organizer
  第108回日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-20K16993
[Presentation] 切除不能進行肝癌に対する分子標的治療薬の腎機能に与える影響2021
- Author(s)
  佐々木龍、中尾一彦
- Organizer
  第24回肝癌分子標的研究会
- Data Source
  KAKENHI-PROJECT-20K16993
[Presentation] 切除不能進行肝癌に対するLenvatinib長期使用例の特徴とon demand TACE併用の意義2021
- Author(s)
  佐々木龍、中尾一彦
- Organizer
  第44回日本肝臓学会西部会
- Data Source
  KAKENHI-PROJECT-20K16993
[Presentation] 切除不能進行肝癌に対するLenvatinib中止後の後治療2021
- Author(s)
  佐々木龍、中尾一彦
- Organizer
  第57回日本肝癌研究会
- Data Source
  KAKENHI-PROJECT-20K16993
[Presentation] 大型肝癌に対する分子標的薬の有効性と安全性2021
- Author(s)
  佐々木龍、中尾一彦
- Organizer
  第57回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-20K16993
[Presentation] 80歳以上の高齢切除不能進行肝癌に対する分子標的薬の治療成績2020
- Author(s)
  佐々木龍、中尾一彦
- Organizer
  第56回日本肝癌研究会
- Data Source
  KAKENHI-PROJECT-20K16993
[Presentation] 切除不能進行肝癌に対するLenvatinib投与中の肝予備能への影響2020
- Author(s)
  佐々木龍、中尾一彦
- Organizer
  第22回九州肝癌研究会
- Data Source
  KAKENHI-PROJECT-20K16993
[Presentation] 切除不能進行肝癌に対するLenvatinibの有効性・安全性と年齢との関連2020
- Author(s)
  佐々木龍、中尾一彦
- Organizer
  第116回日本消化器病学会九州支部例会
- Data Source
  KAKENHI-PROJECT-20K16993
[Presentation] 切除不能進行肝癌に対する多剤逐次療法の治療成績2020
- Author(s)
  佐々木龍、中尾一彦
- Organizer
  第22回肝癌分子標的治療研究会
- Data Source
  KAKENHI-PROJECT-20K16993

SASAKI Ryu 佐々木 龍

Sasaki Ryu 佐々木 龍

Research Projects

Research Products

EOB-MRIによる免疫微小環境推定モデルを用いた肝細胞癌薬物療法の治療効果予測Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

A model for predicting adverse events in molecular targeted drug therapy for hepatocellular carcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Impact of lenvatinib on renal function compared to sorafenib for unresectable hepatocellular carcinoma2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Long-term Outcomes and Prognostic Factors of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Evaluating the Role of Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Predicting Treatment Impact of Lenvatinib and Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Liver Function in Older Patients With Unresectable Hepatocellular Carcinoma After Administration of Lenvatinib2021

Author(s)

Journal Title

DOI

Data Source

[Presentation] 切除不能進行肝癌薬物療法（Lenvatinib）における血漿マイオカイン測定の意義2024

Author(s)

Organizer

Data Source

[Presentation] Evaluating the Role of Hepatobiliary Phase of EOB-MRI in Predicting Treatment Impact of Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma2022

Author(s)

Organizer

Data Source

[Presentation] 切除不能進行肝癌に対する薬物療法の治療効果予測とEOB-MRIの有用性2022

Author(s)

Organizer

Data Source

[Presentation] 切除不能進行肝癌薬物療法における治療前EOB-MRI評価の有用性2022

Author(s)

Organizer

Data Source

[Presentation] 実臨床におけるAtezolizumab＋Bevacizumab併用療法の後治療2022

Author(s)

Organizer

Data Source

[Presentation] Atezolizumab/Bevacizumab併用療法の治療効果予測におけるEOB-MRIの有用性2022

Author(s)

Organizer

Data Source

[Presentation] 免疫複合療法時代に再考する切除不能進行肝癌Lenvatinib長期使用例の特徴2022

Author(s)

Organizer

Data Source

[Presentation] 切除不能進行肝癌に対する分子標的治療薬の腎機能に与える影響2021

Author(s)

Organizer

Data Source

[Presentation] 切除不能進行肝癌に対するLenvatinib長期使用例の特徴とon demand TACE併用の意義2021

Author(s)

Organizer

Data Source

[Presentation] 切除不能進行肝癌に対するLenvatinib中止後の後治療2021

Author(s)

Organizer

Data Source

[Presentation] 大型肝癌に対する分子標的薬の有効性と安全性2021

Author(s)

Organizer

Data Source

SASAKI Ryu 佐々木龍

Sasaki Ryu 佐々木龍